Molecular Simplification of 1,4-Diazabicyclo[4.3.0]nonan-9-ones Gives Piperazine Derivatives That Maintain High Nootropic Activity
- 26 October 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (23) , 4499-4507
- https://doi.org/10.1021/jm000972h
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 3-?-tropanyl 2-(4-Cl-phenoxy)butyrate (SM 21): A Review of the Pharmacological Profile of a Novel Enhancer of Cholinergic TransmissionCNS Drug Reviews, 1997
- Cognitive Enhancement Therapy for Alzheimerʼs DiseaseDrugs, 1997
- 7-[3-(1-Piperidinyl)propoxy]chromenones as Potential Atypical AntipsychoticsJournal of Medicinal Chemistry, 1996
- In search of the mechanism of action of the nootropics: New insights and potential clinical implicationsLife Sciences, 1994
- Piracetam and other structurally related nootropicsBrain Research Reviews, 1994
- Long‐term and high‐dose piracetam treatment of Alzheimer's diseaseNeurology, 1993
- Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysisBritish Journal of Pharmacology, 1991
- Psychostimulants, Analeptics, Nootropics: An Attempt to Differentiate and Assess Drugs Designed for the Treatment of Impaired Brain FunctionsPharmacopsychiatry, 1988
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- An Improved One-Trial Passive Avoidance Learning SituationPsychological Reports, 1967